Antidiabetic and anti-obesity potential were evaluated by inhibition of alpha-glucosidase (α-GLU), advance glycation end products (AGEs) formation and pancreatic lipase. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.